Atlas Trials

Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

Clinical trial NCT03429595 · COMPLETED

Trial details

NCT number
NCT03429595
Sponsor
UNION therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Impetigo
Start date
2018-02-23
Primary completion
2018-06-26
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.